Tosoh Bioscience Inc recalls ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative…
- Recall date
- November 30, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0676-2019
- FDA classification
- Class II
- Brand / firm
- Tosoh Bioscience Inc
- Sold / distributed
- US Nationwide
What was recalled
ST AIA-PACK ACTH (ACTH: Adrenocorticotropic Hormone) is designed for IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of Adrenocorticotropic hormone (ACTH) in human EDT A plasma. Measurements of ACTH are used in the differential diagnosis and treatment of certain disorders of the adrenal glands such as Cushing's syndrome, adrenocortical insufficiency and the ectopic ACTH syndrome.
Get recall alerts
Free email alert whenever Tosoh Bioscience Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Tosoh Bioscience Inc